ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness of Group Based Schema Therapy in the Treatment of Personality Disorders

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00247234
Recruitment Status : Completed
First Posted : November 1, 2005
Last Update Posted : September 25, 2017
Sponsor:
Information provided by (Responsible Party):
Norwegian University of Science and Technology

October 31, 2005
November 1, 2005
September 25, 2017
September 2004
June 2011   (Final data collection date for primary outcome measure)
  • quality of life [ Time Frame: 5 years ]
    Self-report measures
  • depression [ Time Frame: 5 years ]
    Self-report measures
  • anxiety [ Time Frame: 5 years ]
    Self-report measures
  • suicidal ideation [ Time Frame: 5 years ]
    Self-report measures
Self-report measure of quality of life, depression, anxiety, suicidal ideation and interpersonal function
Complete list of historical versions of study NCT00247234 on ClinicalTrials.gov Archive Site
Use of psychotropic medication [ Time Frame: 5 years ]
  • * Number of diagnostic criteria (reSCID)
  • * Drop-out rate
  • * Social adjustment
  • * Use of psychotropic medication
Not Provided
Not Provided
 
Effectiveness of Group Based Schema Therapy in the Treatment of Personality Disorders
Effectiveness of Group Based Schema Therapy in the Treatment of Borderline Personality Disorder and Avoidant Personality Disorder
This study intends to compare the effectiveness of schema therapy with standard psychiatric outpatient care for patients with borderline or avoidant personality disorder.
Not Provided
Interventional
Not Applicable
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
  • Personality Disorder, Borderline
  • Avoidant Personality Disorder
  • Behavioral: Schema Therapy
    group based schema therapy
  • Behavioral: standard care
    standard psychiatric out-patient care
  • Experimental: schema therapy
    Intervention: Behavioral: Schema Therapy
  • Active Comparator: standard care
    standard psychiatric out-patient care
    Intervention: Behavioral: standard care
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
90
72
January 2015
June 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Avoidant or Borderline personality disorders

Exclusion Criteria:

  • Do not speak Scandinavian languages
  • Antisocial personality disorder
  • Narcissistic personality disorder
  • Affective bipolar disorder I
  • Schizophrenia
  • Mental impairment/organic brain disorder
  • Substance dependence
  • Planned pregnancy
  • Serious somatic illness
  • Anorexia Nervosa
Sexes Eligible for Study: All
20 Years to 50 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
Norway
 
 
NCT00247234
ursula.falkmer+AEA-stolav.no
No
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Not Provided
Norwegian University of Science and Technology
Norwegian University of Science and Technology
Not Provided
Study Chair: Are Holen, M.D., Ph.D. Department of Neuroscience, NTNU - Faculty of Medicine, MTFS, NO-7489 Trondheim, Norway
Norwegian University of Science and Technology
September 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP